550 related articles for article (PubMed ID: 8540495)
21. Long-term renal sodium handling in patients with cirrhosis treated with transjugular intrahepatic portosystemic shunts for refractory ascites.
Wong W; Liu P; Blendis L; Wong F
Am J Med; 1999 Mar; 106(3):315-22. PubMed ID: 10190381
[TBL] [Abstract][Full Text] [Related]
22. Modified saphenous-peritoneal shunt in refractory ascites: new technique.
Chen JH; Liu HD; Yu JC; Chen CJ; Shih ML; Liu YC; Hsieh CB
ANZ J Surg; 2005 Mar; 75(3):128-31. PubMed ID: 15777390
[TBL] [Abstract][Full Text] [Related]
23. Peritoneovenous shunting for malignant ascites.
Wickremesekera SK; Stubbs RS
N Z Med J; 1997 Feb; 110(1037):33-5. PubMed ID: 9066565
[TBL] [Abstract][Full Text] [Related]
24. [Peritoneovenous diversion using the LeVeen shunt in the treatment of refractory ascites after liver transplantation].
Mabrut JY; de la Roche E; Adham M; Ducerf C; Baulieux J
Ann Chir; 1998; 52(7):612-7. PubMed ID: 9805798
[TBL] [Abstract][Full Text] [Related]
25. Differences in long-term survival after transjugular intrahepatic portosystemic shunt for refractory ascites and variceal bleed.
Membreno F; Baez AL; Pandula R; Walser E; Lau DT
J Gastroenterol Hepatol; 2005 Mar; 20(3):474-81. PubMed ID: 15740494
[TBL] [Abstract][Full Text] [Related]
26. Peritoneovenous shunt insertion for intractable ascites: a district general hospital experience.
Hussain FF; Meer ZF; Lopez AJ
Cardiovasc Intervent Radiol; 2004; 27(4):325-8. PubMed ID: 15346206
[TBL] [Abstract][Full Text] [Related]
27. Prognosis assessment of patients with refractory ascites treated with a peritoneovenous shunt.
Nitta H; Okamura S; Mizumoto T; Matsushita H; Nishimura T; Shimokawa Y; Kimura M; Baba H
Hepatogastroenterology; 2013 Oct; 60(127):1607-10. PubMed ID: 24634930
[TBL] [Abstract][Full Text] [Related]
28. [Prognostic factors for survival in cirrhosis].
Ennaifer R; Ouakaa-Kchaou A; BelHadj N; Elloumi H; Gargouri D; Kochlef A; Kilani A; Romani M; Kharrat J; Ghorbel A
Tunis Med; 2007 Dec; 85(12):1039-43. PubMed ID: 19170384
[TBL] [Abstract][Full Text] [Related]
29. Ascites in cirrhosis: a review of management and complications.
Kuiper JJ; van Buuren HR; de Man RA
Neth J Med; 2007 Sep; 65(8):283-8. PubMed ID: 17890787
[TBL] [Abstract][Full Text] [Related]
30. The diagnostic and predictive value of ascites nitric oxide levels in patients with spontaneous bacterial peritonitis.
Garcia-Tsao G; Angulo P; Garcia JC; Groszmann RJ; Cadelina GW
Hepatology; 1998 Jul; 28(1):17-21. PubMed ID: 9657091
[TBL] [Abstract][Full Text] [Related]
31. [Palliative treatment of carcinomatous ascites with peritoneovenous shunt].
Castellví Suaña JM; Baliellas Comellas C; Fabregat Prous J; Torras Torra J; Guardiola Capón J; Sánchez Gili M
Rev Esp Enferm Dig; 1992 Nov; 82(5):331-3. PubMed ID: 1485985
[TBL] [Abstract][Full Text] [Related]
32. Peritoneovenous shunting for intractable ascites.
Tyden G; Samnegård H; Thulin L
Acta Chir Scand; 1982; 148(7):597-600. PubMed ID: 7168289
[TBL] [Abstract][Full Text] [Related]
33. [Retransfusion of ascites fluid in cirrhotic patients, using external peritoneovenous and peritoneopulmonary shunts (personal technic)].
Mircea N; Constantinescu C; Jianu E; Constantinescu N
Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir; 1984; 33(1):45-54. PubMed ID: 6233645
[No Abstract] [Full Text] [Related]
34. Prognostic factors of survival in complicated viral and alcoholic cirrhosis without hepatocellular carcinoma. A retrospective study.
Spadaro A; Luigiano C; De Caro G; Morace C; Tortorella V; Bonfiglio C; Pagano N; Consolo P; Alibrandi A; Ajello A; Ferraù O; Freni MA
Minerva Gastroenterol Dietol; 2007 Dec; 53(4):311-9. PubMed ID: 18043549
[TBL] [Abstract][Full Text] [Related]
35. Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death.
Heuman DM; Abou-Assi SG; Habib A; Williams LM; Stravitz RT; Sanyal AJ; Fisher RA; Mihas AA
Hepatology; 2004 Oct; 40(4):802-10. PubMed ID: 15382176
[TBL] [Abstract][Full Text] [Related]
36. Effects of ascites resolution after successful TIPS on nutrition in cirrhotic patients with refractory ascites.
Allard JP; Chau J; Sandokji K; Blendis LM; Wong F
Am J Gastroenterol; 2001 Aug; 96(8):2442-7. PubMed ID: 11513188
[TBL] [Abstract][Full Text] [Related]
37. Management of ascites. A review.
Watanabe A
J Med; 1997; 28(1-2):21-30. PubMed ID: 9249607
[TBL] [Abstract][Full Text] [Related]
38. Serum bilirubin and platelet count: a simple predictive model for survival in patients with refractory ascites treated by TIPS.
Bureau C; Métivier S; D'Amico M; Péron JM; Otal P; Pagan JC; Chabbert V; Chagneau-Derrode C; Procopet B; Rousseau H; Bosch J; Vinel JP
J Hepatol; 2011 May; 54(5):901-7. PubMed ID: 21145798
[TBL] [Abstract][Full Text] [Related]
39. [Treatment of hydrothorax in patients with cirrhosis using a peritoneo-jugular shunt].
Etienne G; Belghiti J; Farges O; Benhamou JP; Fékété F
Ann Chir; 1989; 43(9):717-9. PubMed ID: 2604358
[TBL] [Abstract][Full Text] [Related]
40. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.
Ripoll C; Groszmann R; Garcia-Tsao G; Grace N; Burroughs A; Planas R; Escorsell A; Garcia-Pagan JC; Makuch R; Patch D; Matloff DS; Bosch J;
Gastroenterology; 2007 Aug; 133(2):481-8. PubMed ID: 17681169
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
